Remdesivir likely to be highly effective antiviral against SARS-CoV-2 for some patients
The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists. Writing in Nature
Dec. 14, 2020 • ~7 min
spotlight-on-future-therapeutics future-therapeutics infectious-diseases covid-19 coronavirus immunology
Recruitment underway as Cambridgeshire NHS trusts join COVID-19 vaccine trial
Recruitment has begun at three leading Cambridgeshire NHS Trusts for volunteers to take part in the nationwide COVID-19 vaccine trial.
June 11, 2020 • ~3 min
spotlight-on-future-therapeutics future-therapeutics infectious-diseases covid-19 coronavirus
Repurposing existing drugs for COVID-19 a more rapid alternative to a vaccine, say researchers
Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology.
May 7, 2020 • ~6 min
spotlight-on-future-therapeutics medicine future-therapeutics covid-19 coronavirus
World’s first artificial pancreas app licensed for people with type 1 diabetes in UK
The world’s first licensed, downloadable artificial pancreas app for people with type 1 diabetes launches today, based on over a decade of research by Professor Roman Hovorka at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust.
March 16, 2020 • ~5 min
spotlight-on-future-therapeutics future-therapeutics type-1-diabetes diabetes app
Cambridge research team working towards vaccine against COVID-19
The race is on to find a vaccine against the new COVID-19 coronavirus. Professor Jonathan Heeney explains why a cautious approach is needed and how his team is using new technology developed for influenza and Ebola viruses to target the new infection.
March 13, 2020 • ~6 min
spotlight-on-future-therapeutics future-therapeutics infectious-diseases
Study highlights potential for ‘liquid health check’ to predict disease risk
Proteins in our blood could in future help provide a comprehensive ‘liquid health check’, assessing our health and predicting the likelihood that we will we will develop a range of diseases, according to research published today in Nature Medicine.
Dec. 2, 2019 • ~7 min
spotlight-on-future-therapeutics future-therapeutics diagnostic protein proteomics
Cambridge joins new transatlantic research alliance to detect cancer at its earliest stage
Cambridge scientists are set to benefit from a major cash injection from Cancer Research UK and partners to develop radical new strategies and technologies to detect cancer at its earliest stage.
Oct. 21, 2019 • ~8 min
physics future-therapeutics cancer
University Enterprise Zone aims to drive innovation across Cambridge
Cambridge is to establish a University Enterprise Zone as part of a new government initiative announced today by Universities Minister Chris Skidmore.
Sept. 20, 2019 • ~3 min
innovation future-therapeutics
Cambridge Heart and Lung Research Institute receives major funding boost
Chris Skidmore, Minister for Universities, Science, Research and Innovation, today announced a £30 million award to the University of Cambridge to support the new Cambridge Heart and Lung Research Institute (HLRI).
July 10, 2019 • ~5 min
heart-disease spotlight-on-public-health future-therapeutics cardiovascular-disease-cvd cardiorespiratory cystic-fibrosis
/
1